A series of heteroaromatic analogs of pregabalin has been identified that possess anticonvulsant activity in the DBA/2 mouse model. The methods of synthesis and preliminary pharmacology are discussed herein. (C) 2005 Elsevier Ltd. All rights reserved.
A series of heteroaromatic analogs of pregabalin has been identified that possess anticonvulsant activity in the DBA/2 mouse model. The methods of synthesis and preliminary pharmacology are discussed herein. (C) 2005 Elsevier Ltd. All rights reserved.
\(57) [Abstract] The invention is a series of novel compounds useful in the treatment of epilepsy, fainting spells, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders, e.g. irritable bowel syndrome (IBS) and inflammation, particularly arthritis.含有本发明化合物的药物组合物,以及生产这些化合物的方法,包括对生产最终化合物有用的新中间体。\n
3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS
申请人:Warner-Lambert Company LLC
公开号:EP1185524B1
公开(公告)日:2005-01-26
3-heteroarylalkyl substituted GABA analogs
申请人:——
公开号:US20040127724A1
公开(公告)日:2004-07-01
The invention is a novel series of compounds which are useful in the treatment of epilepsy, faintness attacks, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders such as irritable bowel syndrome (IBS), and inflammation, especially arthritis. A pharmaceutical composition containing a compound of the invention as well as methods of preparing the compounds and novel intermediates useful in the preparation of the final compounds are included.